The present invention relates to use of lipidic compounds, and more particularly medium-chain length fatty acids, their salts, their triglycerides or mixtures thereof, in the treatment of pancreatic cancer in human patients. Particular aspects of the invention relate to the use of capric acid and/or lauric acid in combination with chemotherapeutic agents such as gemcitabine, erlotinib, or both.本發明係有關於脂類化合物,及更詳細地係有關於中等鏈長脂肪酸、其等的鹽類、其等的三酸甘油酯或其混合物,在治療人類病患的胰臟癌之用途。本發明的特定方面係有關於與化學治療劑諸如健擇他濱(gemcitabine)、厄洛替尼(erlotinib)或二者組合使用之癸酸及/或月桂酸。
